INFU on NYSE
InfuSystem Holdings, Inc
American surgical and medical instruments and apparatus company. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Neuronetics, Inc., Xtant Medical (United States) or Heartflow, Inc., or pick any stock.
- TickerINFU on NYSE2
- IndustrySurgical & Medical Instruments & Apparatus2
- HeadquartersRochester Hills, United States2
- Incorporated inDE3
- Business address3851 West Hamlin Road, Rochester Hills, Mi 483093
- Filer categoryAccelerated filer, Smaller reporting company3
- Legal formCorporation2
- LEI549300F58N8PHJ4QUI592
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O REGISTERED AGENT SOLUTIONS, INC., 19904 Dover, United States2
- Registered withDivision of Corporations, Department of State, 40118412
See how the biggest companies compare on our leaderboards
InfuSystem Holdings, Inc. ("we," "us," "our" or the "Company") is a Delaware corporation. Formed in 2005, the Company operates through its subsidiary InfuSystem, Inc., a Delaware corporation ("InfuSystem" or "ISI").4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Patient Services And Device Solutions brought in 44% of the revenue InfuSystem Holdings, Inc broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Patient Services And Device Solutions | $106.3M | $113.1M |
| Patient Services | $72.8M | $78.2M |
| Device Solutions | $61.7M | $64.1M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue44¢$63.1M
- Other costs49¢$69.7M
- Income tax3¢$4.0M
- Profit5¢$6.6M
Out of $143.4M in revenue.5
Where each dollar of operating cash went, fiscal 2025
- Capital spending2¢$560.0K
- Share buybacks40¢$9.9M
- Kept or used elsewhere57¢$14.0M
Out of $24.4M of cash from operations.5
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net revenues | $143.4M | $134.9M |
| Cost of revenues | $63.1M | $64.5M |
| Gross profit | $80.3M | $70.4M |
| Amortization of intangibles | $920.0K | $991.0K |
| Selling and marketing | $10.5M | $11.3M |
| General and administrative | $57.0M | $51.2M |
| Total selling, general and administrative | $68.4M | $63.5M |
| Operating income | $11.9M | $6.9M |
| Interest expense | -$1.3M | -$1.8M |
| Other income (expense) | $2.0K | -$55.0K |
| Income (Loss) before income taxes | $10.6M | $5.1M |
| Provision for income taxes | -$4.0M | -$2.7M |
| Basic (in dollars per share) | $0.32 | $0.11 |
| Diluted (in dollars per share) | $0.31 | $0.11 |
| Basic (in shares) | 20.7M shares | 21.3M shares |
| Diluted (in shares) | 21.1M shares | 21.7M shares |
| Net income | $6.6M | $2.3M |
| Unrealized gain (loss) on hedges | -$733.0K | $40.0K |
| (Provision for) benefit from income tax on unrealized hedge gain (loss) | $179.0K | -$9.0K |
| Other comprehensive income (loss) | -$554.0K | $31.0K |
| Net comprehensive income | $6.1M | $2.4M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $3.2M | $527.0K | |
| Accounts receivable, net | $22.9M | $21.2M | |
| Inventories, net | $5.4M | $6.5M | |
| Other current assets | $4.9M | $4.0M | |
| Total current assets | $36.3M | $32.2M | |
| Medical equipment for sale or rental | $4.6M | $3.2M | |
| Medical equipment in rental service, net of accumulated depreciation | $34.5M | $39.2M | |
| Property & equipment, net of accumulated depreciation | $3.4M | $4.0M | |
| Goodwill | $3.7M | $3.7M | |
| Intangible assets, net | $6.9M | $6.5M | |
| Operating lease right of use assets | $4.2M | $5.4M | |
| Deferred income taxes | $4.6M | $7.2M | |
| Derivative financial instruments | $748.0K | $1.5M | |
| Other assets | $1.7M | $878.0K | |
| Total assets | $100.6M | $103.6M | |
| Accounts payable | $10.8M | $9.8M | |
| Other current liabilities | $9.4M | $7.8M | |
| Total current liabilities | $20.2M | $17.7M | |
| Long-term debt, net of current portion | $19.6M | $23.9M | |
| Operating lease liabilities, net of current portion | $3.4M | $4.6M | |
| Total liabilities | $43.2M | $46.1M | |
| Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued | $0 | $0 | |
| Common stock, $0.0001 par value: authorized 200,000,000 shares; 20,209,636 shares issued and outstanding as of December 31, 2025 and 21,272,351 shares issued and outstanding as of December 31, 2024 | $2.0K | $2.0K | |
| Additional paid-in capital | $117.5M | $113.9M | |
| Accumulated other comprehensive income | $565.0K | $1.1M | |
| Retained deficit | -$60.7M | -$57.5M | |
| Total stockholders equity | $57.3M | $57.5M | $52.3M |
| Total liabilities and stockholders equity | $100.6M | $103.6M | |
| Preferred stock, par value (usd per share) | $0.00 | $0.00 | |
| Preferred stock, authorized (in shares) | 1.0M shares | 1.0M shares | |
| Preferred stock, issued (in shares) | 0 shares | 0 shares | |
| Common stock, par value (usd per share) | $0.00 | $0.00 | |
| Common stock,, authorized (in shares) | 200.0M shares | 200.0M shares | |
| Common stock, issued (in shares) | 20.2M shares | 21.3M shares | |
| Common stock, outstanding (in shares) | 20.2M shares | 21.3M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $3.2M | $527.0K | |
| Accounts receivable, net | $22.9M | $21.2M | |
| Inventories, net | $5.4M | $6.5M | |
| Other current assets | $4.9M | $4.0M | |
| Total current assets | $36.3M | $32.2M | |
| Medical equipment for sale or rental | $4.6M | $3.2M | |
| Medical equipment in rental service, net of accumulated depreciation | $34.5M | $39.2M | |
| Property & equipment, net of accumulated depreciation | $3.4M | $4.0M | |
| Goodwill | $3.7M | $3.7M | |
| Intangible assets, net | $6.9M | $6.5M | |
| Operating lease right of use assets | $4.2M | $5.4M | |
| Deferred income taxes | $4.6M | $7.2M | |
| Derivative financial instruments | $748.0K | $1.5M | |
| Other assets | $1.7M | $878.0K | |
| Total assets | $100.6M | $103.6M | |
| Accounts payable | $10.8M | $9.8M | |
| Other current liabilities | $9.4M | $7.8M | |
| Total current liabilities | $20.2M | $17.7M | |
| Long-term debt, net of current portion | $19.6M | $23.9M | |
| Operating lease liabilities, net of current portion | $3.4M | $4.6M | |
| Total liabilities | $43.2M | $46.1M | |
| Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued | $0 | $0 | |
| Common stock, $0.0001 par value: authorized 200,000,000 shares; 20,209,636 shares issued and outstanding as of December 31, 2025 and 21,272,351 shares issued and outstanding as of December 31, 2024 | $2.0K | $2.0K | |
| Additional paid-in capital | $117.5M | $113.9M | |
| Accumulated other comprehensive income | $565.0K | $1.1M | |
| Retained deficit | -$60.7M | -$57.5M | |
| Total stockholders equity | $57.3M | $57.5M | $52.3M |
| Total liabilities and stockholders equity | $100.6M | $103.6M | |
| Preferred stock, par value (usd per share) | $0.00 | $0.00 | |
| Preferred stock, authorized (in shares) | 1.0M shares | 1.0M shares | |
| Preferred stock, issued (in shares) | 0 shares | 0 shares | |
| Common stock, par value (usd per share) | $0.00 | $0.00 | |
| Common stock,, authorized (in shares) | 200.0M shares | 200.0M shares | |
| Common stock, issued (in shares) | 20.2M shares | 21.3M shares | |
| Common stock, outstanding (in shares) | 20.2M shares | 21.3M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income | $6.6M | $2.3M |
| Provision for doubtful accounts | $200.0K | -$167.0K |
| Depreciation | $12.4M | $11.5M |
| Loss on disposal of and reserve adjustments for medical equipment | $519.0K | $942.0K |
| Gain on sale of medical equipment | -$3.3M | -$2.3M |
| Amortization of intangible assets | $920.0K | $991.0K |
| Amortization of deferred debt issuance costs | $81.0K | $78.0K |
| Stock-based compensation | $4.4M | $4.5M |
| Deferred income taxes | $2.7M | $1.9M |
| Accounts receivable | $263.0K | -$701.0K |
| Inventories | $1.1M | -$126.0K |
| Other current assets | -$903.0K | $202.0K |
| Other assets | $114.0K | $2.0M |
| Accounts payable and other liabilities | -$708.0K | -$676.0K |
| NET CASH PROVIDED BY OPERATING ACTIVITIES | $24.4M | $20.5M |
| Acquisition of business | -$1.4M | $0 |
| Purchase of medical equipment | -$8.1M | -$16.7M |
| Purchase of property and equipment | -$560.0K | -$1.1M |
| Proceeds from sale of medical equipment, property and equipment | $3.3M | $4.6M |
| NET CASH USED IN INVESTING ACTIVITIES | -$6.8M | -$13.2M |
| Principal payments on long-term debt | -$52.3M | -$56.1M |
| Cash proceeds from long-term debt | $48.2M | $50.8M |
| Debt issuance costs | -$197.0K | $0 |
| Common stock repurchased as part of share repurchase program | -$9.9M | -$1.2M |
| Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans | -$1.1M | -$816.0K |
| Cash proceeds from exercise of options and ESPP | $335.0K | $387.0K |
| NET CASH USED IN FINANCING ACTIVITIES | -$15.0M | -$6.9M |
| Net change in cash and cash equivalents | $2.7M | $296.0K |
| Cash paid for interest | $1.2M | $1.7M |
| Cash paid for income taxes | $543.0K | $753.0K |
| Additions to medical equipment and property | $3.1M | $1.4M |
No quarter-by-quarter statement was filed.
Leadership
Who has led InfuSystem Holdings, Inc, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerCarrie Lachance Sep 25, 2025 to now13
- Chief executive officerRichard Dilorio Dec 12, 2017 to Sep 25, 202514
- Chief executive officerEric K. Steen Apr 1, 2013 to Mar 22, 201715
- Chief executive officerDilip Singh Apr 26, 2012 to Apr 26, 201216
- Chief executive officerSean McDevitt Dec 7, 2010 to Jan 27, 201217
- Chief executive officerSteven Watkins Nov 21, 2007 to Apr 7, 200918
- ChairRyan J. Morris Apr 26, 2012 to May 13, 201419
- PresidentCarrie Lachance Mar 3, 2021 to now20
- PresidentRichard Dilorio Mar 13, 2019 to Jan 24, 202221
- PresidentEric K. Steen Aug 18, 2016 to Mar 22, 201722
- Chief financial officerWesley W. Winnekins Mar 23, 2020 to Mar 23, 202023
- Chief financial officerBarry G. Steele Apr 1, 2020 to now24
- Chief financial officerGregory Schulte May 9, 2018 to May 17, 201925
- Chief financial officerJonathan P. Foster Mar 22, 2012 to Aug 18, 201526
- Chief financial officerJames M. Froisland Dec 20, 2010 to Mar 17, 201127
- Chief financial officerSean Whelan Nov 16, 2007 to Jun 4, 201028
- Chief financial officerErin Suzanne Enright Apr 20, 2006 to Sep 10, 200729
- Chief operating officerCarrie Lachance Oct 9, 2019 to now30
- Chief operating officerJanet Skonieczny Jan 4, 2013 to Sep 8, 201731
Board members and other officers (41)
- EVP-Chief HR OfficerJerod Funke Oct 19, 2023 to now32
- Executive VP and CIOAddam Chupa Nov 4, 2022 to now33
- VP and ControllerKevin Whitman Feb 19, 2019 to Sep 8, 202234
- VP OF SALES AND MARKETINGThomas Mark Ruiz Feb 20, 2019 to Sep 6, 202235
- Chief Administrative OfficerJeannine Sheehan Apr 29, 2019 to May 23, 202236
- DirectorScott Shuda Jun 17, 2019 to Mar 31, 202037
- Exec VP,CAO & Corp ControllerTrent N. Smith May 4, 2017 to Sep 8, 201738
- Executive Vice PresidentRichard Dilorio May 18, 2017 to Sep 8, 201739
- Chief Information OfficerMichael Milton McReynolds Nov 13, 2014 to Aug 18, 201640
- EVP, Gen. Counsel & Corp. Sec.Sean William Schembri Nov 13, 2014 to Aug 18, 201641
- OfficerRyan J. Morris May 11, 2012 to May 11, 201242
- SecretaryPat Lavecchia Apr 20, 2006 to Oct 16, 200743
- Board memberJohn J. Sviokla Jun 16, 2025 to now44
- Board memberBeverly A. Huss May 21, 2024 to now45
- Board memberKenneth D. Eichenbaum May 22, 2024 to now46
- Board memberRonald T. Hundzinski Nov 18, 2024 to now47
- Board memberRalph F. Boyd Jr. May 17, 2022 to May 23, 202448
- Board memberR. Rimmy Malhotra Sep 23, 2022 to Sep 8, 202349
- Board memberCarrie Lachance May 21, 2021 to now50
- Board memberPaul Andrew Gendron May 16, 2019 to now51
- Board memberTerry L. Armstrong Jul 23, 2018 to Aug 27, 201852
- Board memberRonald H. Peele Jr. Jul 24, 2018 to Aug 27, 201853
- Board memberChristopher R. Sansone Jun 30, 2017 to Nov 21, 202254
- Board memberDarrell B. Montgomery Aug 16, 2017 to May 20, 202155
- Board memberRichard Dilorio Aug 16, 2017 to now56
- Board memberScott Shuda Sep 16, 2016 to now57
- Board memberGregg Owen Lehman May 13, 2014 to Jun 20, 202358
- Board memberEric K. Steen Apr 1, 2013 to Mar 22, 201715
- Board memberCharles M. Gillman Apr 26, 2012 to Apr 26, 201259
- Board memberDilip Singh Apr 26, 2012 to Apr 26, 201216
- Board memberJohn M. Climaco Apr 26, 2012 to Apr 26, 201260
- Board memberJoseph E. Whitters Apr 26, 2012 to Aug 27, 201861
- Board memberRyan J. Morris May 11, 2012 to May 19, 201742
- Board memberTimothy L. Kopra Apr 19, 2010 to Dec 7, 201062
- Board memberJames L. Freddo Apr 28, 2008 to Dec 7, 201063
- Board memberDavid C. Dreyer May 1, 2008 to Oct 17, 201864
- Board memberSteven Watkins Nov 21, 2007 to Apr 7, 200918
- Board memberJean-Pierre Millon Apr 20, 2006 to Dec 7, 201065
- Board memberPat Lavecchia Apr 20, 2006 to Dec 7, 201043
- Board memberWayne P. Yetter Apr 21, 2006 to Aug 27, 201566
- Board memberSean McDevitt Apr 25, 2006 to Jan 27, 201267
Former names
Timeline
- Sep 25, 2025New chief executive Carrie Lachance becomes CEO13
- Dec 12, 2017New chief executive Richard Dilorio becomes CEO14
- Apr 1, 2013New chief executive Eric K. Steen becomes CEO15
- Apr 26, 2012New chief executive Dilip Singh becomes CEO16
- Dec 7, 2010New chief executive Sean McDevitt becomes CEO17
- Nov 21, 2007New chief executive Steven Watkins becomes CEO18
- Aug 15, 2005Founded InfuSystem Holdings, Inc is founded2
Filings
295 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 102 major events, 137 insider forms, 20 large holders, 16 other. The latest 20:
- Oct 13, 20264 EDGAR
- Sep 17, 20268-K EDGAR
- Sep 11, 20264 EDGAR
- Aug 4, 202610-Q EDGAR
- Aug 4, 20268-K EDGAR
- Aug 4, 20268-K EDGAR
- Jul 28, 2026SCHEDULE 13G EDGAR
- Jul 28, 20268-K EDGAR
- May 19, 20264 EDGAR
- May 19, 20264 EDGAR
- May 19, 20264 EDGAR
- May 19, 20264 EDGAR
- May 18, 20268-K EDGAR
- May 18, 2026S-8 EDGAR
- May 14, 20264 EDGAR
- May 14, 20264 EDGAR
- May 14, 20264 EDGAR
- May 14, 20264 EDGAR
- May 14, 20264 EDGAR
- May 14, 20264 EDGAR
The 295 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
68 open-market trades by officers, directors and large owners since October 2021: 21 buys and 47 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 11, 2026 | Lachance CarriePresident and CEO | Buy | 1,000 | $8.46 | $8.5K | Form 4 |
| May 8, 2026 | GENDRON PAUL ANDREWDirector | Buy | 5,000 | $8.88 | $44.4K | Form 4 |
| May 8, 2026 | Lachance CarriePresident and CEO | Buy | 2,000 | $8.83 | $17.7K | Form 4 |
| May 8, 2026 | Steele Barry GExecutive VP and CFO | Buy | 7,000 | $8.71 | $61.0K | Form 4 |
| Mar 2, 2026 | Steele Barry GExecutive VP and CFO | Buy | 2,064 | $9.16 | $18.9K | Form 4 |
| Aug 22, 2025 | Shuda ScottDirector | Sale | 5,752 | $9.67 | $55.6K | Form 4 |
| May 28, 2025 | Eichenbaum Kenneth D.Director | Buy | 2,000 | $5.18 | $10.4K | Form 4 |
| May 19, 2025 | Hundzinski Ronald TDirector | Buy | 5,000 | $6.09 | $30.4K | Form 4 |
| May 16, 2025 | Lachance CarriePresident and CEO | Buy | 1,967 | $6.10 | $12.0K | Form 4 |
| May 15, 2025 | Lachance CarriePresident and CEO | Buy | 1,165 | $6.01 | $7.0K | Form 4 |
| May 14, 2025 | Steele Barry GExecutive VP and CFO | Buy | 3,000 | $5.76 | $17.3K | Form 4 |
| Nov 27, 2024 | Dilorio RichardChief Executive Officer | Sale | 5,398 | $8.87 | $47.9K | Form 4 |
| Nov 26, 2024 | Dilorio RichardChief Executive Officer | Sale | 14,602 | $8.91 | $130.1K | Form 4 |
| Nov 25, 2024 | Dilorio RichardChief Executive Officer | Sale | 20,000 | $9.32 | $186.4K | Form 4 |
| Sep 23, 2024 | Eichenbaum Kenneth D.Director | Buy | 4,000 | $5.89 | $23.6K | Form 4 |
| May 23, 2024 | BOYD RALPH F JRDirector | Buy | 4,000 | $7.13 | $28.5K | Form 4 |
| May 22, 2024 | HUSS BEVERLY ADirector | Buy | 4,300 | $6.86 | $29.5K | Form 4 |
| May 21, 2024 | Chupa AddamExecutive VP and CIO | Buy | 1,000 | $6.67 | $6.7K | Form 4 |
| May 20, 2024 | Steele Barry GExecutive VP and CFO | Buy | 3,000 | $6.47 | $19.4K | Form 4 |
| May 20, 2024 | Funke JerodEVP-Chief HR Officer | Buy | 1,000 | $6.39 | $6.4K | Form 4 |
All 68 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- BlackRockSCHEDULE 13G, 1 filing Jul 28, 202668
- Minerva Advisors LLCSCHEDULE 13G/A, 2 filings Dec 3, 2025 to Feb 17, 202669
- AWM Investment Company, Inc.SCHEDULE 13G/A, 5 filings Feb 14, 2023 to Nov 13, 202570
- VANGUARD GROUP INCSCHEDULE 13G/A, 2 filings Feb 13, 2024 to Jul 29, 202571
- SANSONE ADVISORS, LLCSCHEDULE 13D/A, 4 filings Nov 29, 2023 to Jan 22, 202572
- Scott ShudaSC 13D/A, 2 filings Mar 28, 2023 to Dec 6, 202473
- Acuitas Investments, LLCSCHEDULE 13G/A, 3 filings Jan 12, 2023 to Nov 7, 202474
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGARDilip Singh, Chief executive officer
- 17
- 18
- 19SEC EDGARRyan J. Morris, Chair
- 20SEC EDGARCarrie Lachance, President
- 21SEC EDGARRichard Dilorio, President
- 22SEC EDGAREric K. Steen, President
- 23
- 24
- 25
- 26
- 27
- 28SEC EDGARSean Whelan, Chief financial officer
- 29
- 30
- 31
- 32SEC EDGARJerod Funke, EVP-Chief HR Officer
- 33SEC EDGARAddam Chupa, Executive VP and CIO
- 34SEC EDGARKevin Whitman, VP and Controller
- 35
- 36
- 37SEC EDGARScott Shuda, Director
- 38
- 39
- 40
- 41
- 42SEC EDGARRyan J. Morris, Officer
- 43SEC EDGARPat Lavecchia, Secretary
- 44SEC EDGARJohn J. Sviokla, Board member
- 45SEC EDGARBeverly A. Huss, Board member
- 46SEC EDGARKenneth D. Eichenbaum, Board member
- 47SEC EDGARRonald T. Hundzinski, Board member
- 48SEC EDGARRalph F. Boyd Jr., Board member
- 49SEC EDGARR. Rimmy Malhotra, Board member
- 50SEC EDGARCarrie Lachance, Board member
- 51SEC EDGARPaul Andrew Gendron, Board member
- 52SEC EDGARTerry L. Armstrong, Board member
- 53SEC EDGARRonald H. Peele Jr., Board member
- 54SEC EDGARChristopher R. Sansone, Board member
- 55SEC EDGARDarrell B. Montgomery, Board member
- 56SEC EDGARRichard Dilorio, Board member
- 57SEC EDGARScott Shuda, Board member
- 58SEC EDGARGregg Owen Lehman, Board member
- 59SEC EDGARCharles M. Gillman, Board member
- 60SEC EDGARJohn M. Climaco, Board member
- 61SEC EDGARJoseph E. Whitters, Board member
- 62SEC EDGARTimothy L. Kopra, Board member
- 63SEC EDGARJames L. Freddo, Board member
- 64SEC EDGARDavid C. Dreyer, Board member
- 65SEC EDGARJean-Pierre Millon, Board member
- 66SEC EDGARWayne P. Yetter, Board member
- 67SEC EDGARSean McDevitt, Board member
- 68
- 69
- 70
- 71
- 72
- 73
- 74